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Abstract: This paper addresses the question of how Responsible Research and Innovation (RRI) can
be implemented in Small and Medium-Sized Enterprises (SMEs). It builds on existing knowledge
about RRI in business as well as on insights into motivations, drivers and barriers from the related
fields of eco-innovation and sustainability innovation. Expert interviews with CEOs of SMEs in the
Austrian medical device sector are analyzed to develop insights into the companies’ research and
innovation activities and potential drivers and barriers for RRI. The findings support the assumption
that SMEs are largely unaware of the RRI concept. At the same time, however, it is possible to identify
current practices that already operationalize aspects of RRI. It is argued that SMEs could build upon
existing practices to further develop ways of being responsible and that implementation of RRI
should be in line with specific organizational and contextual factors.
Keywords: responsible research and innovation; small and medium-sized enterprises; drivers and barriers;
medical devices; Austria
1. Introduction
The concept of Responsible Research and Innovation (RRI) deals with the conflicting objectives of
economic growth, competitive advantage, and the well-being of society [1–4]. Similar to conceptions
of eco-innovation and sustainability innovation, RRI is based on the idea that societal well-being
and innovative progress can mutually reinforce each other, and that social and environmental
considerations can create economic benefits and business opportunities [5,6]. So far, however, evidence
on how to implement RRI in businesses is limited [7–9]. Furthermore, insights into business reasons
for implementation (such as expected value-added for business), as well as into drivers to support and
barriers that might impede implementation, are scarce [10].
Small and Medium-Sized Enterprises (SMEs) are the focus of this study, as they make up 99% of
all companies in Europe and have been under-researched with regard to the practical implementation
of RRI (for a notable exception see Pavie and colleagues [11]). The European Commission defines
SMEs as companies with less than 250 employees and a turnover of less than EUR 50 Mio [12]. SMEs
provide two-thirds of total employment and are responsible for over 50% of value generation in the
European Union [13]. Due to their ability to quickly adapt to changing contexts and high levels of
internal flexibility, SMEs are considered a driving force of innovation. At the same time, SMEs also
face considerable constraints with regard to their access to financial resources and their ability to
build up organizational structures [14]. It is understandable, therefore, that responsibility issues are
not at the core of SMEs’ agendas and that they are more concerned about keeping their business
running or succeeding on the market [11]. From this, two questions arise: (1) Why do SMEs engage
in research and innovation activities and what are the critical factors?; and (2) How do these factors
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influence responsible business practices in those SMEs and what are potential drivers and barriers for
implementing the concept of RRI?
The study aims to provide answers to the two research questions by building on existing
knowledge about RRI and findings from related literature on eco-innovation and sustainability
innovation. It gathers first-hand insights into research and innovation activities in SMEs and potential
drivers for and barriers to RRI from eight expert interviews with CEOs of Austrian medical device
SMEs. Interviews are analyzed by means of qualitative content analysis. The findings suggest that the
RRI concept can be compatible with practices that are already being implemented in the investigated
companies, that moral motivations could open a door to the implementation of RRI, and that policy
to facilitate the implementation of RRI practices could benefit from connecting to existing company
practices that are already in line with RRI.
Following this introduction, we provide an overview of the current state of knowledge about
RRI and draw lessons from pertinent eco-innovation and sustainability innovation approaches.
We introduce the context of the Austrian medical device sector and present findings from the interview
analysis. Finally, we discuss the most important findings in the context of the existing literature,
demonstrate the limitations of the research, and suggest practical implications and further research.
2. Background
2.1. Responsible Research and Innovation (RRI)
While the roots of RRI can be traced back to the early 1990s [15], the concept has gained particular
visibility in European policy-making and research communities since 2011. The RRI concept originates
in discourses on emerging technologies and research ethics in contested innovative fields, such as
nanotechnologies or geo-engineering [15], and has been predominantly driven by European research
and innovation policy over the past several years. A first working definition of RRI was proposed by
von Schomberg [16] as a: “transparent, interactive process by which societal actors and innovators become
mutually responsive to each other with a view on the (ethical) acceptability, sustainability and societal desirability
of the innovation process and its marketable products (in order to allow a proper embedding of scientific and
technological advances in our society)” [16]. In spite of ongoing debates about the definition of RRI [17]
and the concept’s continuous development [18], a common, general agreement about the meaning
and key aspects of RRI has developed [9] in the form of four dimensions that would lead towards
more responsible innovation processes [15,17,19], entailing a collective and continuous commitment
to conduct research and innovation processes in an anticipatory, reflective, inclusive (deliberative),
and responsive way [19]. At the same time, the European Commission has been promoting responsible
research and innovation by funding projects on the thematic elements of ethics, gender and diversity,
public engagement, open access, and science education through the previous and current European
Framework Programmes “FP7” and “Horizon 2020”.
2.2. Responsible Research and Innovation in Business
At this point in time, evidence of how RRI should be put into practice is still limited [18,20,21].
So far, RRI has been “developed and introduced in a top-down manner by policy makers and scientists” [8] (p. 3)
and not yet been translated into practices that are compatible with corporate research and innovation
objectives, processes and underlying rationales. A growing number of publicly funded projects
and private initiatives have been researching or applying RRI over the past decade [22]; however,
only a few of these address businesses specifically [18,22]. More recent studies have aimed to shed
light on the implementation of responsible innovation practices in businesses. These studies indicate
that businesses in Europe still seem to be operating without an awareness of the RRI concept [18,20,21],
but that extant practices, processes and purposes exhibit indications of responsible innovation [23].
Moreover, a growing body of literature has been dealing with questions of how to incentivize
or drive companies to adopt the concept [7,10,24] or particular RRI principles [25,26]. First good
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practice examples of implementation of RRI in business provide a diverse set of company practices;
ranging from inclusive governance and a general orientation of company research and innovation
towards tackling societal challenges to institutionalized opportunities for anticipation and reflection, as
well as to targeted activities aimed at increasing gender balance or fostering science education [27,28].
2.3. Insights from Sustainability Innovation and Eco-Innovation
The aim of this paper is to add to this growing body of empirical evidence on drivers of, and barriers
to, incorporating RRI in business. It builds on insights from the related fields of eco-innovation and
sustainability innovation [29–32]. Similar to the concept of RRI, definitions of sustainability innovation
reflect the general difficulty of defining a concept that stretches across social and environmental issues [33].
In contrast, the field of eco-innovation has been more clearly defined as being concerned with processes
that significantly decrease environmental impacts [34]. Both strands of literature provide valuable
insights into the practical implementation of innovative products, processes, services or business models
with positive impact on the environment (and society) by distinguishing between motivations, drivers
and barriers.
Businesses’ motivations for conducting sustainability innovation are manifold. On the one hand,
they imply moral and ethical obligations [35], which center around the morality of products and
services, their effects on human beings, and social issues within global value chains [33]. Environmental
concerns play an important role when making innovation related decisions [36,37], reflecting
society’s desire to protect the environment. Economic motivations, on the other hand, cannot be
ignored when businesses adopt sustainability innovation. According to Alvarez et al. [38], competitive
motivations positively relate to the implementation of environmental practices in a company.
Opportunities to improve the productivity or to reduce costs are expected from changes of business
processes and products [39]. A more comprehensive approach is offered by Bansal and Roth [40] who
suggest ecological responsibility, competitive advantage and the desire to achieve legitimization are
the main motivations for conducting eco-innovation. Moreover, the implementation of sustainability
is said to strongly depend on the intrinsic motivations of key individuals in companies [41,42].
The sustainability innovation and eco-innovation literature also displays several drivers that are
important for their implementation in businesses. Based on technology push and market pull factors
from traditional innovation theory, and considerations of environmental policies, determinants can be
classified into supply-side factors, demand-side factors and policy framework [29,30]. Supply-side
factors include technological and managerial capabilities, tangible and intangible assets as well
as knowledge and skills that enable companies to develop eco-innovations. Collaborations with
research institutes, private or public agencies, and universities are also acknowledged as important
sources of external knowledge. Demand-side factors include market demand [43] and the way the
company is perceived by its target group of customers [44]. The regulatory framework includes
laws, regulations and standards, such as the European Commission’s Eco-Management and Audit
Scheme (EMAS) or standards developed by the International Organization for Standardization
(ISO standards), and is considered an important driver for the implementation of eco-innovations in
businesses [39]. In a similar manner, Kesidou and Demirel [45] differentiate between demand-side
factors, organizational capabilities and the regulatory framework. The multi-impulse model [31,32] is
another explanatory approach of factors “pushing” or “pulling” innovation towards sustainability.
This is based on Schumpeter’s model of creative response [21] which outlines innovation as a result
of the creative performance of actors under specific framework conditions, in which a combination
of factors exert influence on the innovation process. It illustrates company-internal (company vision,
key individuals) and company-external influences (technological developments, market demand,
regulation, civil society) on an innovation process.
Eco-innovation and sustainability innovation literature has further identified a number of
barriers that might be useful in investigating factors that hamper the implementation of RRI in
business. These include organizational shortcomings, such as a weak technological infrastructure,
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a lack of commitment from company executives or an oppositional corporate culture [33]. Financial
issues, such as budget constraints or unpredictable costs, might also impede the implementation of
eco-innovation [46]. Some scholars mention the lack of finance and seed capital in the market as one
of the main barriers to eco-innovation, while others identify the inability of companies to convince
investors of their business plans [33]. In the absence of financial resources, the regulatory framework
is important for stimulating sustainability innovation. However, respective policies and standards
vary considerably across nations and sectors and frequently change over time, making it difficult for
companies to plan for the long-term [33].
3. Medical Device Innovation and the Empirical Setting
The investigation of potential drivers and barriers for the implementation of RRI in SMEs in
one specific context calls for the analysis of a sector that is defined by high innovation rates, a large
percentage of SMEs, and a strong level of societal interest in the “responsible” production of products
and services. The medical device industry is generally known for being research and development
sensitive, being characterized by relatively few leading multi-national companies and a great number
of SMEs that produce a wide variety of products [47]. While the large firms (such as Siemens, Toshiba
and General Electrics) tend to focus on incrementally improving their existing products, SMEs invest
in developing radically different products, which are then either patented and licensed to other firms
or healthcare providers or bought up by the larger firms [48]. Products associated with medical devices
are highly diverse, ranging from high-technology devices, such as surgical and medical instruments
or X-rays, to low-technology devices, such as hospital beds, wheelchairs, bandages or syringes [49].
Recently, information and communication technologies (ICT), data processing and digital solutions
have transformed the industry, resulting in medical devices that require new ways of interaction and
ethical considerations between customers and suppliers.
Innovation processes in the medical device sector have been the subject of much scholarly
attention [50–52]. These rely on scientific advancements in other technological fields [53,54] and
close collaboration with other companies, as well as with physicians, patients, hospitals and medical
research universities [55,56]. Identified factors driving or hampering medical device innovation
include the science base, the national healthcare system and intellectual property rights as influences
on innovative development [55]. National healthcare systems determine the regulatory framework,
funding support, procurement and reimbursement efforts, and demand from the home market [55].
Medical device regulations are important to ensure safety and effectiveness for the patient [56].
Ethical issues, such as access to, and pricing of, medical devices are also considered to be important
dimensions of policy-making [57]. Entrepreneurial performance is often driven by the prior experiences
of entrepreneurs at incumbent companies [50] and benefits from user involvement in the development
of medical devices [58,59].
In Austria, medical devices are a cornerstone of the health industry. In 2014, a total of 487 medical
device companies were located in Austria, of which 124 actively performed research, development and
manufacturing activities [47]. More than 90% of them are SMEs and work in different technological
fields. Innovation activities in the Austrian medical device sector mostly center on digital solutions,
such as software for medicine, telemedicine, e-health and electromechanical medical devices, followed
by more traditional technological activities, such as hospital hardware, diagnostic instruments,
or therapeutic radiation devices. Funding required for developing these innovations is mostly sourced
internally, while external financing has dropped considerably over the last years, mirroring the fact
that medical device companies have less access to private and public funding, or are increasingly
able to raise capital internally [47]. Public support initiatives promote innovative activities and
remedy financial shortcomings to some extent by means of cluster organizations, business incubators
or technology transfer organizations. They also provide incentives for starting new businesses,
entering collaboration networks or attracting well-known multinational companies to the country.
The high density of medical and technical universities and research organizations in Austria enables
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the production of large quantities of innovation-relevant research output for those companies that are
not able to perform research internally. It also ensures the availability of a highly qualified workforce
capable of further developing such research and putting it into practice. Several other companies
that do not focus exclusively on devices, but supply important components from other technological
fields, or provide related services, support the innovative activities of medical device companies in
Austria [47]. Their knowledge and technological expertise is at the basis of collaborative endeavors
and networking initiatives in this sector.
4. Methods
We apply a qualitative case study approach [60,61] to explore influential factors on research and
innovation activities and their role in implementing RRI in a specific contextual setting. Regulations
and standards in the Austrian medical devices industry are analyzed as contextual factors. Primary
information was gathered in semi-structured, expert interviews with CEOs/founders representing
eight highly innovative SMEs. The focus on one specific sector, namely the medical devices industry,
allows us to take industry-specific, external factors into account (e.g., regulations and funding schemes).
The medical devices sector has been selected for this study because of its immediate societal impact
and its particular relevance for the RRI discourse [10,62]. The sector is defined by high innovation
rates, a large percentage of SMEs, and a high level of societal interest in the “responsible” production
of products and services [47]. Austria is chosen as the geographical area of investigation because the
authors’ prior knowledge about the national context facilitates understanding of contextual factors,
on the one hand, and access to interview partners, on the other. The focus on Austrian SMEs (i.e., SMEs
based in Austria) increases the comparability of the contextual setting.
4.1. Selection of Interview Partners
A combination of strategies was applied in the search for potential interview partners in order
to develop a mostly complete sample. The Austrian Life Science Directory 2015 [47] was scanned for
businesses that meet the following criteria:
• Small or medium sized enterprise (i.e., less than 250 employees);
• Flagged as research, development and manufacturing companies for medical devices;
• In-house research, development or innovation activities (i.e., these activities are not being
outsourced to labs, universities or other facilities);
• Research, development or innovation activities take place in Austrian locations (and not,
for example, in subsidiaries outside of Austria);
• Currently pursuing research, development or innovation activities.
In addition, the selection of companies was confined to directory entries for which a direct contact
person could be identified through online searches. This search in the Austrian Life Science Directory
was complemented through directed online searches among incubators and accelerators, conference
speakers and participants, innovation award winners and undirected keyword searches using different
free online search engines. Interview partners were purposely selected to create a diverse set of
companies from different Austrian regions, of different sizes (measured by the number of employees)
and different levels of maturity (i.e., including start-ups as well as established companies).
4.2. Collection and Analysis of Information
Eight interviews with CEOs were conducted in February and March 2017 in face-to-face settings
(two interviews) or via the telephone (six interviews). In seven of these eight cases, the CEO
was also (one of) the founder(s) of the company, which means that all interview partners were
well-informed about company context, the business model, and ongoing research, development and
innovation activities. All interview partners were willing and able to share information about ongoing
research, development and innovation in their companies, and their perceptions about the meaning of
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“responsibility” within their company context, as well as their assessments of potential drivers for and
barriers to different RRI aspects on their companies, or companies working under similar conditions.
The semi-structured interview guidelines were developed in order to guide the interview from
a general description of company characteristics (including history, structure and goals) towards
company-specific research and innovation processes and practices (including models, regulations,
drivers and external cooperation), the interviewees’ partners’ understanding of responsible research
and innovation, and, following an introduction of RRI by the interviewer, a discussion of the
different RRI elements and potential drivers for and barriers to their implementation. All questions
were open-ended.
With the explicit written permission of each interview partner, interviews were recorded and later
transcribed. Information was analyzed using qualitative content analysis [63]. This particular analytical
technique was chosen because it enables the focus to be placed on specific text passages and extract
and combine information relevant to the two research questions specified beforehand. First, interview
sections relevant to the three overarching content areas were identified in the transcribed raw
material—(a) background information on the company, (b) motivation for conducting research and
innovation and factors influencing research and innovation processes, and (c) understanding of
RRI/responsibility and assessment of drivers and barriers. Second, information was extracted and
coded by applying deductive category application in four consecutive steps: Definition of units of
analysis, definition of categories and characteristics, design of coding guidelines, and display in the
form of tables. An excel file was used to display coded information for each of the 17 categories,
which allowed for separate analysis of information in each of the categories and made it possible to
compare responses from the different interview partners and identify common and complementary
themes and arguments, as well as differences between responses. The presentation of findings in
Section 5 is structured along the lines of the interview guidelines, arranged into four subsections:
Findings from content area (a) background information on the company is presented in the introduction
to the section; findings from content area (b) motivation for conducting research and innovation and
factors influencing research and innovation processes are presented in Sections 5.1 and 5.3; and findings
from content area (c) understanding of RRI/responsibility and assessment of drivers and barriers are
included in Sections 5.2 and 5.4.
5. Findings
This section presents findings from the eight expert interviews. After a brief description of the
SMEs represented by our interview partners, we describe the identified contextual, organizational
and personal factors that influence their research and innovation activities and potentially support or
impede the implementation of RRI.
The companies represented by our interview partners have between three and 70 employees and
were founded between 1998 and 2016. Five of the companies are located in Vienna while two are based
in the western and one in the southern parts of Austria. Four companies were founded to exploit
existing innovations; two as university spin-offs and two through management buy-ins. The other
four companies were founded with the objective to start developing novel technological solutions.
All companies are currently developing or selling innovative medical devices in the areas of electro
mechanics, in vitro diagnostics and software for medicine.
It was possible to identify common personal, organizational and contextual factors that
influence research and innovation activities in the companies represented by our interview partners;
and distinguish them into six categories. These factors are described in the following sections. Personal
factors are differentiated into motivations for conducting research and innovation activities (Section 5.1)
and perceptions of responsibility (Section 5.2). Organizational and contextual factors are described
according to their actual influences on research and innovation activities in the SMEs represented by
our interview partners (Section 5.3) and in terms of the role they could play for driving or impeding
implementation of RRI (Section 5.4).
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5.1. Motivations for Research and Innovation Activities
Overall, research and innovation was generally understood to be a means towards increasing the
company’s success in economic terms. Interview partners reported their company’s aim of meeting
current or expected future market demand through the creation of new technologies or an increase
in market share through improved products. Meeting the needs and expectations of customers was
another prominent response. Needs such as the “well-being and safety of the patients” (interview 13,
paragraph 10) or the “technological improvement of our clients’ products and processes” (interview 11,
paragraph 5) were mentioned. In some cases, in which the companies directly engaged with individual
end users, customer needs corresponded to the needs of society. Motivations such as “improving the
quality of life for people” (interview 4, paragraph 18) or “responding to societal challenges” (interview 5,
paragraph 8) reflect personal motivations to increase societal benefits through the company’s innovative
output. Personal influences include our respondents’ curiosity about their innovation’s potential
success in the market as well as its scientific impact, on the one hand, and increasing the individual
scientist’s scientific reputation, on the other. This rationale was voiced in particular by respondents
who had previously conducted academic research and were curious to find out if their research outputs
would succeed in the market. While, as described above, economic reasoning usually triggered research
and innovation activities in the company, some of the motivations put forward by our respondents
imply both responsibility and economic reasoning. The intention of one interviewee, for example,
“to meet the needs of all our stakeholders” (interview 9, paragraph 4) not only indicates a motivation to
fulfill the financial interests of investors, but also implies the maintenance of the jobs of their employees.
5.2. Perceptions of Responsibility
In another open-ended question respondents were asked about their understanding of the concept
of RRI and “responsibility” in general; with respect to their company. The aim of this question was
to give our interview partners the opportunity to express their understanding of their company’s
responsibility before providing them with our definition (as laid out in Section 2) and whether they had
already come across the RRI concept. We were curious to see what RRI aspects could be identified in
our respondents’ different responsibility perceptions, what they consider as responsible innovation and
the extent to which such responsibility aspects are taken up in their research and innovation processes.
Overall, responses suggest that our interview partners were not aware of the RRI concept but that
they have been implementing particular aspects of RRI without being aware of the fact that these
were part of a particular research and innovation policy. Companies, for example, demonstrate their
anticipative and reflective capabilities by considering potential negative consequences of their research
and innovation, by anticipating future challenges and opportunities resulting from new regulations
or directives, or by reflecting upon their target groups’ needs and values. Or as one interviewee put
it: “As an entrepreneur I’m always trying to anticipate what comes next, what difficulties, what obstacles
or what challenges same as opportunities. So this is a permanently ongoing process [ . . . ].” (interview 6,
paragraph 17). The customization of innovation processes according to the needs of their different
customers and their consideration of different societal challenges, such as migration or a two-tier health
service suggest a certain degree of diversity and inclusion among the firms interviewed. The responsive
and adaptive character of the SMEs’ innovation processes becomes evident in their ability to quickly
adapt to changing market conditions. The high degree of flexibility was indeed considered essential
for succeeding in the market and meeting their customers’ interests; an ability that often distinguishes
them from their larger competitors. Openness and transparency of research and innovation processes
become evident in the respondents’ desire to avoid the reproduction of already existing technologies.
Openness in the sense of open access to their research results, however, is also considered to restrict
innovation activities as it is impractical for gaining a competitive advantage, and eventually achieving
sufficient returns on investment. Overall, we find that our respondents not only consider profit related
and economic reasons when making research and innovation decisions, but also the possibility to
“do something good” (interview 6, paragraph 10).
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5.3. Factors Driving or Impeding Research and Innovation
Overall, it was possible to identify organizational and contextual factors of high importance for
research and innovation activities in the SMEs represented by our interview partners. These factors
are largely in line with findings from the literature introduced in Section 2 but are specific with
regard to their empirical setting as outlined in Section 3. The factors that drive or impede research
and innovation in the SMEs are distinguished into six categories (see Table 1) and described in the
following subsections.
Table 1. Drivers for and barriers to innovation.
Factor Categories Drivers Supporting Innovation Barriers Obstructing Innovation
Regulatory framework
- Regulations drive demand
for technologies
- ISO certification and laws require
implementation of quality
management systems
- ISO certification process leads to
market focus
- Regulatory and certification processes
require financial and personnel recourses
- Insufficient information about regulations
and processes
Funding and finance
- Personal and public funding offset lack of
financial resources
- Limited access to financial resources due to
risk aversion of investors
- Cash flow problems due to lack of
marketable products
Market orientation
- Knowledge about technological trends
inspires new innovation
- Learning from competitors, partners and
other stakeholders
- Understanding market trends for
developing innovation for the market
Customer knowledge
- Knowledge about the needs and
requirements of customers
- Inspiration for innovative ideas and
technological improvement
- Customer engagement required during
certification procedures and clinical tests
Management and
organizational structures
- Structures facilitate distribution of tasks
and internal procedures
(e.g., certification)
- Lack of management and organizational
structures due to lack of
entrepreneurial experience
- Lack of planning of innovation processes
- Unable to produce marketable results
External knowledge from
collaborations and networks
- Offset limited internal structures
and knowledge
- Access to management and
technical know-how
- Limited access to highly skilled employees
- Dependency interests of
different stakeholders
5.3.1. Regulatory Framework
The regulatory framework generally plays a crucial role in the different companies’ ambitions
to generate innovation. It not only governs the direction of their technological development but also
influences how research and innovation is managed. One interviewee argued that: “[ . . . ] the wrong
therapy or [if we] make the wrong treatment with this patient and eventually the patient might be harmed or even
die. And then we cannot say, sorry there was a little mistake, I copied the wrong algorithm or I had a headache.
This is not possible. This is why we are in a regulated business.” (interview 11, paragraph 13). Specific ISO
certifications, such as ISO 13485 [64] and medical device laws and their direct impact on research and
innovation processes were pointed out by our respondents. The ISO 13485 certification requires them
to have a quality management system and quality control procedures in place to help document and
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reduce potential risks of innovation processes. The interviews also revealed that the ISO certification
process can stimulate innovative activities, eventually guiding innovative outcomes more towards
market release. Such certification procedures are usually dealt with at early stages of the innovation
process in order to avoid delays and an overload of demand on personnel resources when entering the
market. They also involve clinical testing and ethical compliance checks to ensure the effectiveness
of medical devices and the physical integrity of the patient. However, the regulatory framework
is considered not only to drive innovation, but also to cause delays in the companies’ research and
innovation processes due to insufficient information about regulations and a lack of financial and
personnel resources to cope with them.
5.3.2. Funding
Funding turned out to be one of the crucial factors influencing research and innovation. Interview
partners report considerable problems in accessing internal and external funding sources. During the
early stages of their respective company’s lifetime, they reported considerable cash-flow problems,
which was primarily attributed to the fact that large finance provides are likely to refrain from
investing in medical device SMEs until they have developed a marketable innovative product and
the risks and benefits are more predictable. Or as one interviewee stated: “[...] in vitro diagnostics
is a slow moving, many regulatory hurdles, type of business and is not very easy and attractive for venture
capitalists to go into that, at an early stage. It gets more interesting when you are on the market.” (interview 8,
paragraph 3). Personal funds and public funding sources are a popular alternative. In addition,
pre-seed and seed-funding from local or national funding agencies has proven attainable and useful to
our respondents. External funding from private investors and business angels was named as another
opportunity once a company matures, the first research results become visible and the company’s
market viability can be assessed. Private investors and business angels are reported to have two
important functions: First, they provide larger amounts of funding that allows SMEs to focus on their
research and innovation activities, and second, they often contribute expertise and advice on how to
turn academic research and innovation into marketable products and services.
5.3.3. Market Orientation
Knowledge about the market was identified as another crucial factor influencing innovation
processes. This includes understanding of technological trends, market dynamics and the needs
of different stakeholders in the market. Knowledge about these issues is considered indispensable
for developing marketable innovative products and services. According to our interview partners
such knowledge usually results from previous working experiences as academics or professionals
in the medical devices field. As one interviewee puts it: “So the innovation was driven by looking at
available technology, which we have a deep understanding because we have been working for the market leader.
They have about 85% global market share. And we know all the technologies out there and we did our own
analysis of what type of technology we would like to have to overcome all the problems with existing concept
and technology.” (interview 8, paragraph 5). Interestingly, knowledge about the market is not only
considered to be essential for directing research and innovation activities but also as an important
source for innovative inspiration.
5.3.4. Customer Knowledge
The importance of customer knowledge for innovation activities was emphasized by different
respondents. Many of them put forward the idea that the implementation of a medical technology
requires a deep understanding of their customers’ needs. Products or technological improvements
of already existing products that would not fit their customers’ requirements would simply have no
impact on the market. For that reason, the companies cooperate closely with their customers during
the whole research and innovation process. As described in the words of one interviewee: “[ . . . ]
we see how the needs emerge, how they change, we get feedback from customers, this drives also our product
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development and we have ideas.” (interview 11, paragraph 5). The ISO certification and respective quality
standards further require the companies to continuously gather feedback from their customers and
conduct clinical tests with hospitals and doctors.
5.3.5. Management and Organizational Structures
Management and organizational structures facilitate the distribution of tasks and internal
procedures. Our respondents describe regulated internal procedures and distribution of tasks to
have a positive influence on their innovation activities. They facilitate the implementation of quality
management systems and other technological standards necessary to fulfill medical device-related
regulations. However, a lack of time and personnel resources prevents them from developing such
structures within the companies. Without these structures: “Contracts, ethic commission, etc., hard
to do with a small company in a small environment where you do not have a legal department but you do
need to handle all this.” (interview 6, paragraph 6). However, as a positive outcome of this lack of
structure, companies name high levels of flexibility in adapting to the needs and expectations of
different customers and stakeholders.
5.3.6. External Knowledge from Collaborations and Networks
External knowledge from collaborations and networks plays an important role in our respondents’
innovation processes. Highly skilled employees are considered important for turning innovative ideas
into concrete research and innovation results. Technical know-how, knowledge about Intellectual
Property Rights (IPRs) and the ability to absorb and implement external knowledge such as customer
feedback in innovation processes are of particularly high value in these companies. Interview partners
report a lack of internal technological capabilities and management expertise and, consequently,
a dependency on external knowledge about markets, customers, IPRs and technological expertise
provided by universities, other businesses or funding agencies. External knowledge providers often
come from the CEOs’ personal networks. This means that the CEOs’ previous working experiences
strongly influence the selection of collaboration partners and the ways research and innovation
processes are managed. One interviewee stated: “[ . . . ] from my former company, I still have a strong
network and I can use this network and there is long term relationships and trust on both sides.” (interview
6, paragraph 6). Collaboration with universities allows further development of the technological
aspects of innovative products, and collaborations with large companies are used to open up markets,
and access international distribution networks and managerial advice or financial resources.
5.4. Potential Drivers for and Barriers to the Implementation of RRI
Potential drivers for and barriers to the implementation of RRI in the companies represented by
our interview partners can be distinguished into the same six categories of factors as described in
Section 5.3. These potential drivers and barriers (see Table 2) are described in the following subsections.
Table 2. Potential drivers for and barriers to RRI.
Factor Categories Drivers Supporting Implementation of RRI Barriers Obstructing Implementation of RRI
Regulatory framework
- RRI implementation required by law
- Threatened fines for not meeting RRI standards
- Governments promote RRI and a comprehensible
development strategy for SMEs
- Information about RRI and ethical support
from regulatory bodies
- Unclear regulatory focus and changing
regulatory framework at different
geographical scales
- Theory-driven regulations divorced
from reality
- Lack of information and support measures
about RRI
Funding and finance
- European and national funding agencies
require attention to societal and gender aspects
- Increased access to European and national
funding when considering RRI aspects
- Higher innovation costs expected from
RRI implementation
- Additional financial resources required for
RRI implementation
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Table 2. Cont.
Factor Categories Drivers Supporting Implementation of RRI Barriers Obstructing Implementation of RRI
Market orientation
- Future economic value expected from taking
up RRI
- Growth potential and benefits expected from
taking up RRI
- Expected cost reductions from
implementing RRI
- Lack of a qualified female workforce in the
labor market
- Cost and success pressures paired with
uncertain outcomes from RRI
- Shareholder value and profit maximization
thinking paired with unclear innovative and
profit potentials
Customer knowledge
- Increased company reputation and visibility
among (potential) customers expected from
complying with RRI
- Compliance with their customers’ internal
rules (certain RRI aspects)
- Increased customer engagement can hamper
finding consensus among stakeholders
Management and
organizational structures
- Ethical and responsible thinking and societal
considerations of founder, managers or
employees to comply with RRI aspects
- Employees transfer understanding of
responsibility from previous companies
- Internal codes of conduct advocated by
management require employees to comply
with RRI
- Lack of knowledge about RRI and how to
implement RRI aspects requires strong
personnel efforts
- Personal attitudes and experiences of founders
conflicts with RRI aspects
- Lack of governance structures in SMEs affects
uptake of RRI
- Long-established (sometimes conservative)
governance structures prevent the introduction of
structural change in companies




- Compliance with their innovation partners’
responsibility rules or codes of conduct (large
RRI advocates)
- Increased company reputation and visibility
among potential collaboration partners
expected from complying with RRI
- Innovation partners advocate their own
interests and affect decision making and the
likelihood of resistance to RRI
5.4.1. Regulatory Framework
In the specific context of our interview partners, regulations can be considered as one of the most
effective factors driving the implementation of RRI. Such regulations could be enforced in the form
of RRI standards that companies have to conform to; such as in the case of gender quotas in public
sector-related companies, or in the case of ethics clearance for clinical studies. The promotion of RRI
aspects and its benefits are considered necessary for a broader uptake but should be aligned with the
needs of SMEs. Respondents emphasize the fact that they would require additional information about
RRI and its benefits as well as clear guidance on how to implement the concept into their research
and innovation processes. This lack of information and support is highlighted as a main barrier to
implementing RRI. Respondents further criticize a generally fast-changing regulatory framework and
the complexity of policy processes at different geographical levels. According to one interviewee who
stressed the fact that: “[ . . . ] the people who make these rules and regulations they act from a too much further
position which is too much into theory. And not into living practice.” (interview 11, paragraph 17) companies
also question the theoretical conception of RRI, and its insufficient translation into practicable measures
for SMEs.
5.4.2. Funding and Financing
Financial resources are not only considered essential for successful research and innovation,
but also for introducing the concept of RRI to SMEs. A lack of financial resources, particularly in
the early stages of company development, increases our respondents’ willingness to implement RRI
aspects in return for easier access to financial support; or as one interviewee stated: “[...] if there
are external motivations like access to funding and so on then this is always a driver to make you consider
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these things and put some more policies or whatever on paper for your employees to follow.” (interview 8,
paragraph 25). They also refer to European and national funding agencies that already promote the
consideration of societal impacts or gender quotas. According to one respondent: “a further uptake
of RRI aspects within public funding requirements would further push its implementation.” (interview 12,
paragraph 25, translated from German to English). At the same time, however, stricter requirements
for RRI in research and innovation processes are expected to put pressure on the companies’ financial
resources; it might cause an increase in their cost structure and a need to hire more qualified staff able
to translate responsibility aspects into beneficial innovation and organizational structures.
5.4.3. Market Orientation
Respondents share the view that the implementation of RRI in practice will be strongly dependent
on market dynamics. As described above, research and innovation activities are generally pursued
to gain positive future economic value and long-term profits (see Section 5.3.1). A clear incentive for
the respondents to implement RRI in their companies would be the prospect of growth or reduction
of costs. Gender aspects are mentioned as a potential barrier by one interviewee who refers to the
relatively small pool of qualified female workers with a technical background in the medical device
market, which would make it difficult to fulfill a gender quota. In this context, one respondent also
mentions that: “the “cost for developing medical products will rise incredibly and small companies will not be
able to afford it. So I’d say, a discrimination against small companies.” (interview 11, paragraph 16); large
competitors tend to have easier access to sparse financial and personnel resources, thus aggravating
the disparities in the situation even further. In addition, a potential increase of costs and the continuous
pressure to succeed on the market impede these companies in implementing RRI in their research and
innovation processes.
5.4.4. Customer Knowledge
Respondents claim that better access to customers would increase the likelihood of RRI
implementation among SMEs. The important role assigned to customers throughout the research and
innovation process makes these companies open to approaches that help them improve and intensify
collaboration. A potential increase of company reputation and visibility among (potential) customers
would increase our respondents’ willingness to implement RRI. One interviewee stated: “[ . . . ] if it
is necessary to portray yourself responsibly and we would expect a benefit from that we would agree to that.”
(interview 5, paragraph 26, translated from German to English). Internal codes of conduct imposed
by their customers are also considered important drivers for adopting RRI principles in the research
and innovation process. When customers are large companies they could drive the implementation
of RRI by requiring them to adhere to ethical codes of conducts, training or other quality procedures.
In contrast, the increased involvement of customers in the research and innovation process is also
expected to hamper consensus finding among the companies’ different stakeholders. This would not
only drastically slow down their research and innovation process but also use up a large proportion of
their financial and personnel resources.
5.4.5. Management and Organizational Structures
Management and organizational structures are considered important to facilitate the uptake of
RRI aspects. These structures could drive RRI by specifying responsibilities for taking ethical, social or
other actions into account and support the commitment of employees to implementing RRI. A lack of
such structures makes it difficult to assess risks and benefits and would impede the implementation of
RRI. The personal attitudes and prior experiences of founders, managers or employees can heavily
influence the way RRI aspects are considered, and whether they are expected to yield positive effects
on innovation processes or outcomes. One interviewee also emphasized the important role of company
executives for introducing the RRI concept to a company’s employees: “[ . . . ] this is also what our
employees are aware of and what I tell them.” (interview 11, paragraph 13).
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5.4.6. External Knowledge from Collaborations and Networks
Our respondents expect external collaboration and networks to be potential drivers of RRI.
This includes enforced compliance with collaboration partners’ responsibility rules or codes of conduct.
Some of the respondents have already been confronted with RRI aspects through collaboration with
universities and large business partners. One interviewee reported: “I know from the companies we
worked in the past with, they always had these annual or half yearly integrity training which was basically
a computer questionnaire that you had to fill out [ . . . ].” (interview 8, paragraph 12). Codes of conduct
and ethics trainings were most prominently mentioned by our respondents. According to some of our
respondents, RRI would also attract attention among SMEs if the integration of RRI principles would
yield higher visibility and a better reputation among potential and existing partners and customers.
At the same time, however, they point out that external knowledge providers might be opposed to the
concept of RRI.
6. Discussion of Findings
This study investigates research and innovation activities in the Austrian medical device sector
and links them with RRI practices. In this way, it adds to the growing body of literature on the
implementation of RRI in business [7,10,11]. Understanding of the potential drivers and barriers is
shaped by extant knowledge about the organizational and contextual factors that drive or impede
eco-innovation and sustainability innovation [30–32]. We find that in the case of RRI, traditional
theoretical explanations which build on external and internal influences on research and innovation
activities are helpful. The main findings are discussed below.
6.1. Practicability of the RRI Concept
Overall, our interview partners had no prior knowledge of the RRI concept. This supports
previous observations that SMEs are still largely unaware of RRI [7–9,18,20,21]. When the different
elements of the concept (see Section 2) were explained to them, however, they had no difficulties in
relating them to their company activities and in discussing potential enabling and obstructing factors.
Thus, while the concept itself was unknown to them, it was easy for them to start thinking about the
different elements that constitute it; even if they did not necessarily see advantages in implementing all
of them. The only RRI element that our interview partners had difficulties relating to was the thematic
element of “science education”, as described by the European Commission [65]. Furthermore, interview
partners mentioned a range of different practices that are already being performed in their respective
companies and can already be considered as practices of the different elements that make up RRI.
This includes practices to anticipate the potential consequences of research and innovation activities
on customers and end users (i.e., patients, doctors, and hospitals), the inclusion of many different
stakeholders to compensate for the lack of internal resources, as well as the timely response to new
or changing customer needs. As described in Section 3, the development and use of medical devices
are strongly regulated [57] and the companies represented by our interview partners must adhere
to a variety of national standards and EU directives. Their accounts of high ethical standards in the
medical devices sector reflect previous observations [58]. Engagement of particular stakeholder groups
is common practice in the sector, where close contact with customers and the end user (i.e., the patient)
is necessary to learn about respective needs, expectations and technological trends. Gender aspects
become relevant when applying for public funding, which is an essential source of finance for most
SMEs. These and other examples suggest that the RRI concept can be compatible with some of these
companies’ existing practices.
6.2. Profit-Oriented versus Moral Motivations to Engage with RRI
Recounted reasons to engage in research and innovation activities generally include
profit-oriented elements, but also refer to the generation of positive impact on customers, society,
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or the environment. In relation to previous assumptions that corporate innovation needs to be
developed through collective efforts beyond mere corporate self-interest [17], we find that the
representatives of our group of Austrian medical device SMEs are aware of responsibility issues
and are, in general, interested in increasing their company’s positive impact on them. Recurring
aims are the improvement of patient treatments or a quality improvement in medical devices used
by doctors and in hospitals. Similar findings are shown in studies of other sectors, such as in the
case of ICT for aging people, or the food industry [10,66]. Similar reasons have been documented
for companies that develop eco-innovations or sustainability innovations and are often referred to as
moral or intrinsic motivations [33,35–38,41,42]. This finding suggests that while an expected increase
in profits would likely be a good reason for companies to start looking into ways to implement RRI,
it does not have to be the only starting point. Moral motivations could open a second door to the
implementation of RRI in companies.
6.3. Potential Driving and Impeding Factors for the Implementation of RRI
When the different process dimensions and thematic elements that make up the RRI concept
were explained to them, our interview partners had no difficulties in discussing them, and could
thus provide an expert, first-hand perspective on the potential driving and impeding factors for the
implementation of RRI in SMEs in the Austrian medical device sector (see Table 2 in Section 5.4).
It does not come as a surprise that the potential drivers and barriers they mentioned relate to the
same factors they had already identified as being influential on research and innovation activities in
their respective companies (see Table 1 in Section 5.3). Overall, the different descriptions and lines of
argumentation are complementary and do not contradict one another. Potential drivers and barriers
can easily be integrated into categories developed in the literature on eco-innovation and sustainability
innovation [29,30,33]. We would like to emphasize that, in the perception of our interview partners,
all factors have the potential to act as either drivers or barriers, depending on other situational and
contextual factors. While the prominence of the regulatory framework (including laws, regulations
and required certification) as a potential driver of RRI relates to its significance in previous studies
on eco-innovation and sustainability innovation [29,32], it is, for example, equally emphasized as
a potential barrier to the implementation of RRI when the regulatory focus is unclear, when it is
subject to frequent adjustments, or when information about practical implementation measures is
lacking. External funding, as a second example, was pointed out as an important potential driver
for the implementation of RRI by making adherence to specific practices a requirement for funding.
At the same time, however, interview partners were wary of stricter requirements for public funding in
putting additional strain on their already limited financial resources. As a final example, the personal
attitudes and prior experiences of founders, managers or employees are attributed with the ability
to heavily influence the way RRI aspects are considered within the company, and whether they are
expected to yield positive effects.
Overall, and in line with other authors’ observations [10], an implementation of RRI practices is
more likely to be considered a benefit for a company if it is aligned with existing company practices
and structures [11]. In the case of the Austrian medical device sector, an implementation of RRI
practices could, for example, connect to the extant high level of ethical requirements and standards for
products on the market, as well as to existing practices of user, customer or expert engagement in the
idea-generation and development of novel products, processes or services.
6.4. Limitations and Further Research
The research approach allowed us to gather valuable insights into research and innovation
processes in one particular sector, while the generalizability of the findings is limited by the qualitative
nature and the geographic scope of the study. The influential factors discussed according to the six
categories in Sections 5.3 and 5.4 should not be taken as an exhaustive list of factors that influence
research and innovation processes. Further studies could, for example, explore sectors that are
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characterized by little immediate interaction between innovation producers and the users of the
innovation, and explore the impact of such contextual environments on the perceived drivers for and
barriers to RRI. It would also be useful to further investigate the ambiguities arising within different
factor categories to better define opportunities for practical implementation of RRI in SMEs. Research
and innovation policy-makers could build on these findings, and on previous knowledge from the
fields of eco-innovation and sustainability innovation, to boost implementation of RRI in companies,
and try to connect it to existing practices within a particular sector that already actively reflects upon
elements of RRI.
Acknowledgments: A substantial part of the empirical evidence was collected in the course of the Horizon 2020
project “COMPASS—Evidence and opportunities for responsible innovation in SMEs” (Grant Agreement No. 710543).
The authors would like to thank all project partners for their cooperation. We highlight Kalypso Iordanou’s (UClan CY)
contribution to this research, who led development of the interview guideline and the corresponding task in the
project. We thank our friendly reviewers André Martinuzzi, Florian Findler, Norma Schönherr and Eric Mulholland
at the Institute for Managing Sustainability, WU Vienna University of Economics and Business. We would further like
to thank two anonymous reviewers who have provided us with valuable feedback in the journal’s review process.
Author Contributions: Both authors were involved in developing and reviewing the paper. Alexander Auer
collected the data and undertook the qualitative data analysis, Katharina Jarmai led the conceptual work.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Aho, E.; Cornu, J.; Georghiou, L.; Subirá, A. Creating an Innovative Europe. Report of the Independent
Expert Group on R&D and Innovation Appointed Following the Hampton Court Summit. 2006. Available
online: http://europa.eu.int/invest-in-research (accessed on 30 October 2017).
2. European Commission. The European Union Explained: Research and Innovation; European Commission
Publication Office: Brussels, Belgium, 2014; Available online: http://ec.europa.eu/newsroom/horizon2020/
document.cfm?doc_id=6322 (accessed on 21 December 2017).
3. Ahlstrom, D. Innovation and Growth: How Business Contributes to Society. Acad. Manag. Perspect. 2010, 24,
11–24. [CrossRef]
4. Von Schomberg, R. A Vision of Responsible Research and Innovation. In Responsible Innovation: Managing
the Responsible Emergence of Science and Innovation in Society; Owen, R., Bessant, J., Heintz, M., Eds.;
John Wiley & Sons, Ltd.: Chinchester, UK, 2013; pp. 51–74. [CrossRef]
5. Voegtlin, C.; Scherer, A.G. Responsible innovation and the innovation of responsibility: Governing
sustainable development in a globalized world. J. Bus. Ethics 2017, 143, 227–243. [CrossRef]
6. Porter, M.E.; Kramer, M.R. Creating Shared Value. Harv. Bus. Rev. 2011, 89, 62–77.
7. Gurzawska, A.; Mäkinen, M.; Brey, P. Implementation of Responsible Research and Innovation (RRI) Practices
in Industry: Providing the Right Incentives. Sustainability 2017, 9, 1759. [CrossRef]
8. Lubberink, R.; Blok, V.; van Ophem, J.; Omta, O. Lessons for Responsible Innovation in the Business Context:
A Systematic Literature Review of Responsible, Social and Sustainable Innovation Practices. Sustainability
2017, 9, 721. [CrossRef]
9. Stahl, B.C.; Obach, M.; Yaghmaei, E.; Ikonen, V.; Chatfield, K.; Brem, A. The Responsible Research and
Innovation (RRI) Maturity Model: Linking Theory and Practice. Sustainability 2017, 9, 1036. [CrossRef]
10. Chatfield, K.; Iatridids, K.; Stahl, B.C.; Paspallis, N. Innovating Responsibly in ICT for Ageing: Drivers,
Obstacles and Implementation. Sustainability 2017, 9, 971. [CrossRef]
11. Pavie, X.; Scholten, V.; Carthy, D. Responsible Innovation: From Concept to Practice, 1st ed.; World Scientific Publishing:
Singapore, 2014; ISBN 978-9814525077.
12. European Commission. Commission Recommendation of 6 May 2003 Concerning the Definition of Micro,
Small and Medium-Sized Enterprises; European Commission Publications Office: Brussels, Belgium, 2003;
Available online: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32003H0361 (accessed on
21 December 2017).
13. Eurostat. Statistics on Small and Medium-Sized Enterprises; Eurostat Publication Office: Luxemburg, 2012;
Available online: http://ec.europa.eu/eurostat/statistics-explained/index.php/Statistics_on_small_and_
medium-sized_enterprises#cite_note-7 (accessed on 21 December 2017).
Sustainability 2018, 10, 17 16 of 18
14. Parker, C.M.; Redmond, J.; Simpson, M. A review of interventions to encourage SMEs to make environmental
improvements. Environ. Plan. C Gov. Policy 2009, 27, 279–301. [CrossRef]
15. Owen, R.; Macnagthen, P.; Stilgoe, J. Responsible Research and Innovation: From Science in Society to
Science for Society, with Society. Sci. Public Policy 2012, 39, 751–760. [CrossRef]
16. Von Schomberg, R. Towards Responsible Research and Innovation in the Information and Communication
Technologies and Security Technologies Fields. 2011. Available online: https://papers.ssrn.com/sol3/
papers.cfm?abstract_id=2436399 (accessed on 19 October 2017).
17. Stilgoe, J.; Owen, R.; Mcnaghten, P. Developing a Framework for Responsible Innovation. Res. Policy 2013,
42, 1568–1580. [CrossRef]
18. Blok, V.; Lemmens, P. The Emerging Concept of Responsible Innovation. Three Reasons why it is
Questionable and calls for a Radical Transformation of the Concept of Innovation. In Responsible Innovation,
Volume 2: Concepts, Approaches, and Applications; Koops, B.J., Oosterlaken, I., van den Hoven, J., Romijn, H.A.,
Swierstra, T.E., Eds.; Springer: Dordrecht, The Netherlands, 2015; pp. 19–35. ISBN 978-3-319-17307-8.
19. Owen, R.; Stilgoe, J.; Macnaghten, P.; Gorman, M.; Fisher, E.; Guston, D. A framework for responsible
innovation. In Responsible Innovation: Managing the Responsible Emergence of Science and Innovation in Society;
Owen, R., Bessant, J., Heintz, M., Eds.; John Wiley & Sons, Ltd.: Chinchester, UK, 2013; pp. 51–74. [CrossRef]
20. Davies, S.R.; Horst, M. Responsible Innovation in the US, UK and Denmark: Governance Landscapes.
In Responsible Innovation, Volume 2: Concepts, Approaches, and Applications; Koops, B.J., Oosterlaken, I.,
van den Hoven, J., Romijn, H.A., Swierstra, T.E., Eds.; Springer: Dordrecht, The Netherlands, 2015; pp. 37–56.
ISBN 978-3-319-17307-8.
21. Khan, S.S.; Timotijevic, L.; Newton, R.; Coutinho, D.; Llerena, J.L.; Ortega, S.; Benighaus, L.; Hofmaier, C.;
Xhaferri, Z.; de Boer, A.; et al. The framing of innovation among European research funding actors: Assessing
the potential for ‘responsible research and innovation’ in the food and health domain. Food Policy 2016, 62,
78–87. [CrossRef]
22. Nwafor, C.; Jarmai, K.; Stacherl, B.; Montevecchi, F. Benchmark Report and Policy Paper:
Integration of the RRI Approach into Collaborative R&D&I and SME Participation in European
Funded Collaborative Research in Healthcare, Nanotechnology and ICT. COMPASS, 2017. Available
online: https://innovation-compass.eu/wp-content/uploads/2017/09/D1.4-Benchmark-Report_Integration-
of-the-RRI-approach-into-collaborative-Research-Development-Innovation-.pdf (accessed on 28 October 2017).
23. Asante, K.; Owen, R.; Williamson, G. Governance of new product development and perceptions of responsible
innovation in the financial sector: Insights from an ethnographic case study. J. Responsib. Innov. 2014, 1, 9–30.
[CrossRef]
24. Jenkins, H. A critique of conventional CSR theory: An SME perspective. J. Gen. Manag. 2004, 29, 37–57.
[CrossRef]
25. Iatridis, K.; Kesidou, E. What drives substantive versus symbolic implementation of ISO 14001 in a time of
economic crisis? Insights from Greek manufacturing companies. J. Bus. Ethics 2016, 1–19. [CrossRef]
26. Iatridis, K.; Schroeder, D. Responsible Research and Innovation in Industry. The Case for Corporate Responsibility
Tools, 1st ed.; Springer International Publishing: Heidelberg, Germany, 2016; ISBN 978-3-319-21692-8.
27. Schroeder, D. D1.2 Case Study Descriptions. Deliverable of the FP7 Project RESPONSIBLE-
INDUSTRY. 2014. Available online: http://docs.google.com/viewer?a=v&pid=sites&srcid=
ZGVmYXVsdGRvbWFpbnxyZXNwb25zaWJsZWluZHVzdHJ5d2Vic2l0ZXxneDoyZjdkYmZkNWJmMzVhYzkx
(accessed on 3 December 2017).
28. Schroeder, D. D1.2 Case Study Descriptions. Deliverable of the Horizon 2020 Project COMPASS. 2017. Available
online: https://innovation-compass.eu/wp-content/uploads/2017/07/Deliverable-1_3-Compass-Case-
Study-Descriptions.pdf (accessed on 3 December 2017).
29. Triguero, A.; Moreno-Mondéjar, L.; Davia, M.A. Drivers of different types of eco-innovation in European
SMEs. Ecol. Econ. 2013, 92, 25–33. [CrossRef]
30. Horbach, J. Determinants of environmental innovation—New evidence from German panel data sources.
Res. Policy 2008, 37, 163–173. [CrossRef]
31. Fichter, K. Interpreneurship. Nachhaltigkeitsinnovationen in Interaktiven Perspektiven Unternehmerischen Handelns;
Metropolis-Verlag GmbH: Marburg, Germany, 2005.
Sustainability 2018, 10, 17 17 of 18
32. Hemmelskamp, J. Umweltpolitik und Innovation: Grundlegende Begriffe und Zusammenhänge; ZEW Discussion
Papers, No. 96-23; Zentrum für Europäische Wirtschaftsforschung GmbH: Mannheim, Germany, 1996;
Available online: ftp://ftp.zew.de/pub/zew-docs/dp/dp (accessed on 21 December 2017).
33. Charter, M.; Clark, T. Sustainable Innovation: Key Conclusions from Sustainable Innovation Conferences
2003–2006 Organized by the Centre for Sustainable Design. 2007. Available online: http://research.uca.ac.
uk/694/1/Sustainable_Innovation_report.pdf (accessed on 7 December 2017).
34. Fussler, C.; James, P. Eco-Innovation: A Breakthrough Discipline for Innovation & Sustainability; Pitman Publishing:
London, UK, 1996.
35. Brebels, L.; De Cremer, D.; Van Dijke, M.; Van Hiel, A. Fairness as social responsibility: A moral self-regulation
account of procedural justice enactment. Br. J. Manag. 2011, 22, S47–S58. [CrossRef]
36. Steg, L.; de Groot, J.I. Environmental values. In The Oxford Handbook of Environmental and Conservation
Psychology; Clayton, S.D., Ed.; Oxford Handbooks Online: Oxford, UK, 2012.
37. González-Benito, J.; González-Benito, Ó. Environmental proactivity and business performance: An empirical
analysis. Omega 2005, 33, 1–15. [CrossRef]
38. Alvarez Gil, M.J.; Burgos Jiménez, J.; Céspedes Lorente, J.J. An Analysis of Environmental Management,
Organizational Context and Performance of Spanish Hotels’. Omega 2001, 29, 457–471. [CrossRef]
39. Porter, M.E.; Van der Linde, C. Green and competitive: Ending the stalemate. Harv. Bus. Rev. 1995, 73,
120–134.
40. Bansal, P.; Roth, K. Why Companies Go Green: A Model of Ecological Responsiveness. Acad. Manag. J. 2000,
43, 717–736. [CrossRef]
41. Fichter, K.; Beucker, S.; Noack, T.; Springer, S. Entstehungspfade von Nachhaltigkeitsinnovationen: Fallstudien
und Szenarien zu Einflussfaktoren, Schlüsselakteuren und Internetunterstützung; Fraunhofer-IRB-Verlag:
Stuttgart, Germany, 2007.
42. Fichter, K.; Noack, K.; Beucker, S.; Bierter, W.; Springer, S. Nachhaltigkeitskonzepte für Innovationsprozesse;
Fraunhofer-IRB-Verlag: Stuttgart, Germany, 2006; pp. 1–171. ISBN 3-8167-7.
43. Kammerer, D. The effects of customer benefit and regulation on environmental product innovation: Empirical
evidence from appliance manufacturers in Germany. Ecol. Econ. 2009, 68, 2285–2295. [CrossRef]
44. Pujari, D. Eco-innovation and new product development: Understanding the influences on market
performance. Technovation 2006, 26, 76–85. [CrossRef]
45. Kesidou, E.; Demirel, P. On the drivers of eco-innovations: Empirical evidence from the UK. Res. Policy 2012,
41, 862–870. [CrossRef]
46. Husted, B.W.; Allen, D.B.; Rivera, J.E. Governance choice for strategic corporate social responsibility:
Evidence from Central America. Bus. Soc. 2010, 49, 201–215. [CrossRef]
47. Austria Wirtschaftsservice Gesellschaft mbH (aws). Life Science Report Austria 2015. Austria Wirtschaftsservice
Gesellschaft mbH (aws): Vienna, Austria, 2015. Available online: http://www.lifescienceaustria.at/downloads/
(accessed on 28 October 2017).
48. Tödtling, F.; Sinozic, T.; Auer, A. Knowledge Bases, Multi-Scale Interaction and Transformation of the Vienna
Medical Cluster; SRE Discussion Paper; Vienna University of Economics and Business: Vienna, Austria, 2016;
Volume 3, Available online: http://epub.wu.ac.at/5199/1/Knowledge_bases_Vienna_Medtech_sre-disc-
2016_03.pdf (accessed on 28 October 2017).
49. De Vet, J.M.; Scott, A.J. The Southern Californian medical device industry: Innovation, new firm formation,
and location. Res. Policy 1992, 21, 145–161. [CrossRef]
50. Parthasarthy, R.; Hammond, J. Product innovation input and outcome: Moderating effects of the innovation
process. J. Eng. Technol. Manag. 2002, 19, 75–91. [CrossRef]
51. Chatterji, A.K. Spawned with a silver spoon? Entrepreneurial performance and innovation in the medical
device industry. Strateg. Manag. J. 2009, 30, 185–206. [CrossRef]
52. Nicolini, D. Medical innovation as a process of translation: A case from the field of telemedicine. Br. J. Manag.
2010, 21, 1011–1026. [CrossRef]
53. Von Hippel, E. The dominant role of users in the scientific instrument innovation process. Res. Policy 1976, 5,
212–239. [CrossRef]
54. Von Hippel, E. The Sources of Innovation; Oxford University Press: New York, NY, USA, 1988; ISBN 0-19-504085-6.
Sustainability 2018, 10, 17 18 of 18
55. Gelijns, A.C.; Rosenberg, N. Diagnostic Devices: An Analysis of Comparative Advantages. In Sources of
Industrial Leadership: Studies of Seven Industries; Mowery, D.C., Nelson, R.R., Eds.; Cambridge University Press:
Cambridge, UK, 1999; pp. 312–358. ISBN 052164254.
56. Chatterji, A.K.; Fabrizio, K.R. Using users: When does external knowledge enhance corporate product
innovation? Strateg. Manag. J. 2014, 35, 1427–1445. [CrossRef]
57. Curfman, G.D.; Redberg, R.F. Medical devices—Balancing regulation and innovation. N. Engl. J. Med. 2011,
365, 975–977. [CrossRef] [PubMed]
58. Bergsland, J.; Elle, O.J.; Fosse, E. Barriers to medical device innovation. Med. Devices (Auckl.) 2014, 7, 205–209.
[CrossRef] [PubMed]
59. Shah, S.G.S.; Robinson, I. Benefits of and barriers to involving users in medical device technology
development and evaluation. Int. J. Technol. Assess. Health Care 2007, 23, 131–137. [CrossRef] [PubMed]
60. Smith, S.W.; Shah, S.K. Do innovative users generate more useful insights? An analysis of corporate venture
capital investments in the medical device industry. Strateg. Entrep. J. 2013, 7, 151–167. [CrossRef]
61. Miles, M.B.; Huberman, A.M. Qualitative Data Analysis. An Expanded Sourcebook; Sage Publications:
Thousand Oaks, CA, USA, 1994.
62. Owen, R.; Goldberg, N. Responsible Innovation: A pilot study with the U.K. Engineering and Physical
Sciences Research Council. Risk Anal. 2010, 30, 1699–1707. [CrossRef] [PubMed]
63. Mayring, P. Qualitative Inhaltsanalyse. Grundlagen und Techniken, 11th ed.; Beltz: Wienheim, Germany, 2010.
64. International Organization for Standardization. ISO 13485:2016—Medical Devices—Quality Management
Systems—Requirements for Regulatory Purposes. Available online: https://www.iso.org/standard/59752.html
(accessed on 21 December 2017).
65. European Commission. Responsible Research and Innovation—Europe’s Ability to Respond to Societal Challenges;
European Commission Publications Office: Brussels, Belgium, 2012; Available online: https://ec.europa.eu/
research/swafs/pdf/pub_rri/KI0214595ENC.pdf (accessed on 21 December 2017).
66. Blok, V.; Hoffmans, L.; Wubben, E. Stakeholder engagement for responsible innovation in the private sector:
Critical issues and management practices in the dutch food industry. J. Chain Netw. Sci. 2015, 15, 147–164.
[CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
